Ciprofloxacin in pediatrics: Worldwide clinical experience based on compassionate use - Safety report

Pediatric Infectious Disease Journal

Volumn 16, Issue 1, 1997, Pages 127-129

  Hampel, Barbara ^a,b   Hullmann, Rainer ^a   Schmidt, Heike ^a  

^a BAYER AG   (Germany)

^b Medical Department Germany   (Germany)

Author keywords

arthralgia; arthropathy; Ciprofloxacin; pediatrics; safety

Indexed keywords

CIPROFLOXACIN;

ANTIBIOTIC THERAPY; ARTHRALGIA; CONFERENCE PAPER; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; ARTHRALGIA; CHILD; CIPROFLOXACIN; CLINICAL TRIALS; CYSTIC FIBROSIS; HUMANS; INJECTIONS, INTRAVENOUS;

EID: 0031041430     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199701000-00036     Document Type: Conference Paper

References (10)

1. Ingham B, Brentnall DW, Dale EA, McFadzean JA. Arthropathy induced by antibacterial fused N-alkyl-4-pyridone 3-carboxylic acids. Toxicol Lett 1977;1:21-6.
2. Gough A, Barsoum NY, Mitchell L, McGuire EJ, De La Iglesia FA. Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 1979;51:177-87.
3. Simon C. Im Tierexperiment beobachtete Knorpelsch, digung duch Chinolone. Fortschr Antimikrob Antineoplast Chemother 1984;3:785-8.
4. Stahlmann R, Merker HJ, Hinz N, Chahoud J, Heger W, Neubert D. Ofloxacin in juvenile non-human primates and rats: arthropathia and drug plasma concentrations. Arch Toxicol 1990;64:193-204.
5. Schaad UB, Wedgwood-Krucho J. Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 1987;15:165-8.
6. Data on file. Bayer AG, Wuppertal, Germany.
7. Chysky V, Kapila K, Hullmann R, Arcieri G, Schacht P, Echols R. Quinolones in clinical use: safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use - emphasis on joint evaluation. Infection 1991;19: 289-96.
8. Schacht P, Arcieri G, Branolte J, et al. Worldwide clinical data on efficacy and safety of ciprofloxacin. Infection 1988; 16(Suppl. 1):29-43.
9. Phillips BM, David TJ. Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med 1986;79(Suppl. 12):44-50.
10. Kubin R. Safety and efficacy of ciprofloxacin in paediatric patients: review. Infection 1993;21:413-21.